German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET)

NCT ID: NCT01409330

Last Updated: 2023-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-02-28

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diet intervention according to the German Diabetes Risk Score in newly diagnosed type 2 diabetes.

This study aims to explore the effect of diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) in a multicenter setting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a randomised, multicenter controlled trial Our Aim is to test the effects of an 8-week diet lacking red meat, containing increased fibers and coffee (verum) versus standard recommendation (control)in a multicenter setting.

We are expecting that the verum diet will improve insulin sensitivity and insulin secretion due to reductions in visceral and hepatic fat along with improved adipocyte cytokine secretion profiles

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hypocaloric diet containing increased fibers and coffee

In the intervention group the patients are allowed to eat only white meat and fish. They also need to increase their daily fiber intake to 50grams and drink 5 cups of coffee a day.

Group Type EXPERIMENTAL

diet intervention

Intervention Type DIETARY_SUPPLEMENT

8-week diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) eating red meat.

hypocaloric diet containing red meat

control group (n=20): diet according to the ADA/EASD guidelines (50% carbohydrates, 20% proteins, 30% fat). In the control group the patients should eat 150 grams of red meat a day and are not allowed to consume alcohol, coffee and whole grains.

Group Type ACTIVE_COMPARATOR

diet intervention

Intervention Type DIETARY_SUPPLEMENT

8-week diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) eating red meat.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

diet intervention

8-week diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) eating red meat.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Type 2 diabetic patients
* disease duration for five years or less,
* age of 69 years or less,
* body mass index of 30 kg/m2 or more,
* hemoglobin A1c of 5,5 % to 9%
* patient should be on standard diet or metformin +/- acarbose monotherapy

Exclusion Criteria

* disease duration more than five years,
* age of \> 69 years,
* body mass index of \< 30 kg/m2,
* hemoglobin A1c \< 5,5 % or \> 9%
* if patient becomes insulin therapy
* if patient is non-compliant with study protocol
* if patient is pregnant
* if patient has acute infection
* if patient has anaemia
* if patient has malignancies
* if patient has autoimmune or immune compromising diseases including HIV/AIDS
* if patient has psychiatric diseases or addiction
Minimum Eligible Age

18 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

German Diabetes Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Roden, MD

Role: STUDY_DIRECTOR

German Diabetes Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

German Diabetes Center

Düsseldorf, North Rhine-Westphalia, Germany

Site Status

Charite, Department of Internal Medicine

Berlin, , Germany

Site Status

University Hospital, Department of Internal Medicine III

Dresden, , Germany

Site Status

University Hospital, Department of Internal Medicine I

Heidelberg, , Germany

Site Status

Klinikum der Universität München (KUM)

Munich, , Germany

Site Status

University Hospital, Department of Internal Medicine IV

Tübingen, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Pafili K, Zaharia OP, Strassburger K, Knebel B, Herder C, Huttasch M, Karusheva Y, Kabisch S, Strom A, Nowotny B, Szendroedi J, Roden M. PNPLA3 gene variation modulates diet-induced improvement in liver lipid content in type 2 diabetes. Clin Nutr. 2025 May;48:6-15. doi: 10.1016/j.clnu.2025.02.032. Epub 2025 Mar 6.

Reference Type DERIVED
PMID: 40090039 (View on PubMed)

Karusheva Y, Kunstein L, Bierwagen A, Nowotny B, Kabisch S, Groener JB, Fleitmann AK, Herder C, Pacini G, Strassburger K, Haring HU, Nawroth PP, Pfeiffer AFH, Burkart V, Mussig K, Roden M, Szendroedi J. An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trial. Nutr Metab (Lond). 2018 Dec 29;15:90. doi: 10.1186/s12986-018-0324-5. eCollection 2018.

Reference Type DERIVED
PMID: 30619502 (View on PubMed)

Ziegler D, Strom A, Nowotny B, Zahiragic L, Nowotny PJ, Carstensen-Kirberg M, Herder C, Roden M. Effect of Low-Energy Diets Differing in Fiber, Red Meat, and Coffee Intake on Cardiac Autonomic Function in Obese Individuals With Type 2 Diabetes. Diabetes Care. 2015 Sep;38(9):1750-7. doi: 10.2337/dc15-0466. Epub 2015 Jun 12.

Reference Type DERIVED
PMID: 26070589 (View on PubMed)

Nowotny B, Zahiragic L, Bierwagen A, Kabisch S, Groener JB, Nowotny PJ, Fleitmann AK, Herder C, Pacini G, Erlund I, Landberg R, Haering HU, Pfeiffer AF, Nawroth PP, Roden M. Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: a randomised feasibility trial. Diabetologia. 2015 Feb;58(2):255-64. doi: 10.1007/s00125-014-3457-8. Epub 2014 Nov 26.

Reference Type DERIVED
PMID: 25425219 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DDIET3521

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.